{"id": "ext-001", "agent": "agent-stage2-extract", "input": {"pmid": "12345678", "title": "Effects of caffeine on cognitive performance", "abstract": "Background: Caffeine is widely consumed. Methods: 120 participants randomized to caffeine (200mg) or placebo. Primary outcome: reaction time. Results: Caffeine group showed 15% faster reaction time (p<0.001). Conclusion: Caffeine improves cognitive performance.", "study_type": "rct"}, "expected_output": {"intervention": "caffeine 200mg", "control": "placebo", "outcome_primary": "reaction time", "sample_size": 120, "effect_size": "15% improvement", "p_value": 0.001, "study_design": "randomized controlled trial"}, "tags": ["cognitive", "rct", "pharmacology"]}
{"id": "ext-002", "agent": "agent-stage2-extract", "input": {"pmid": "23456789", "title": "Metformin and cardiovascular outcomes", "abstract": "Objective: Assess metformin's effect on CV events. Design: Retrospective cohort of 5000 T2D patients over 10 years. Main outcome: Major adverse cardiac events (MACE). Findings: Metformin associated with 22% reduced MACE risk (HR 0.78, 95% CI 0.65-0.93). Limitations: Observational design.", "study_type": "cohort"}, "expected_output": {"intervention": "metformin", "control": "standard care", "outcome_primary": "major adverse cardiac events", "sample_size": 5000, "effect_size": "22% risk reduction", "hazard_ratio": 0.78, "confidence_interval": "0.65-0.93", "study_design": "retrospective cohort", "follow_up_years": 10}, "tags": ["cardiology", "diabetes", "cohort"]}
{"id": "ext-003", "agent": "agent-stage2-extract", "input": {"pmid": "34567890", "title": "Mindfulness meditation for anxiety", "abstract": "Background: Anxiety disorders are prevalent. Methods: Meta-analysis of 25 RCTs (n=2500) comparing mindfulness-based interventions to waitlist controls. Outcome: Anxiety severity (GAD-7). Results: SMD=-0.56 (95% CI -0.72 to -0.40), p<0.0001. Heterogeneity: I²=64%. Conclusion: Moderate effect of mindfulness on anxiety.", "study_type": "meta-analysis"}, "expected_output": {"intervention": "mindfulness-based interventions", "control": "waitlist", "outcome_primary": "anxiety severity (GAD-7)", "sample_size": 2500, "effect_size": "SMD=-0.56", "confidence_interval": "-0.72 to -0.40", "p_value": 0.0001, "study_design": "meta-analysis", "n_studies": 25, "heterogeneity": "I²=64%"}, "tags": ["psychiatry", "meta-analysis", "behavioral"]}
{"id": "ext-004", "agent": "agent-stage2-extract", "input": {"pmid": "45678901", "title": "Vitamin D supplementation in elderly", "abstract": "Aim: Determine if vitamin D reduces falls in elderly. Setting: Nursing homes, 800 residents aged 65+. Intervention: Vitamin D3 2000 IU daily vs placebo for 12 months. Primary endpoint: Fall incidence. Results: No significant difference (RR 0.95, 95% CI 0.80-1.13, p=0.56). Adverse events similar between groups.", "study_type": "rct"}, "expected_output": {"intervention": "vitamin D3 2000 IU daily", "control": "placebo", "outcome_primary": "fall incidence", "sample_size": 800, "effect_size": "no significant difference", "relative_risk": 0.95, "confidence_interval": "0.80-1.13", "p_value": 0.56, "study_design": "randomized controlled trial", "duration_months": 12, "population": "elderly 65+"}, "tags": ["geriatrics", "rct", "null-result"]}
{"id": "ext-005", "agent": "agent-stage2-extract", "input": {"pmid": "56789012", "title": "Deep brain stimulation for Parkinson's disease", "abstract": "Introduction: DBS is established for advanced PD. Methods: Systematic review of 18 studies (N=1200). Outcome: UPDRS motor score improvement. Findings: Mean improvement 52% (range 39-68%). Quality of life: significant gains in PDQ-39 scores. Safety: 8% perioperative complication rate.", "study_type": "systematic-review"}, "expected_output": {"intervention": "deep brain stimulation", "control": "medical management", "outcome_primary": "UPDRS motor score", "sample_size": 1200, "effect_size": "52% improvement (range 39-68%)", "study_design": "systematic review", "n_studies": 18, "secondary_outcomes": ["quality of life (PDQ-39)"], "adverse_event_rate": "8% perioperative complications"}, "tags": ["neurology", "systematic-review", "surgery"]}
{"id": "ext-006", "agent": "agent-stage2-extract", "input": {"pmid": "67890123", "title": "SGLT2 inhibitors and heart failure", "abstract": "Background: SGLT2i show promise in HF. Trial: EMPEROR-Preserved, 5988 patients with HFpEF randomized to empagliflozin 10mg daily or placebo. Primary: CV death or HF hospitalization. Median follow-up 26 months. Results: Hazard ratio 0.79 (95% CI 0.69-0.90), p<0.001. NNT: 31. Conclusion: Empagliflozin reduces events in HFpEF.", "study_type": "rct"}, "expected_output": {"intervention": "empagliflozin 10mg daily", "control": "placebo", "outcome_primary": "cardiovascular death or heart failure hospitalization", "sample_size": 5988, "effect_size": "21% risk reduction", "hazard_ratio": 0.79, "confidence_interval": "0.69-0.90", "p_value": 0.001, "study_design": "randomized controlled trial", "follow_up_months": 26, "nnt": 31, "trial_name": "EMPEROR-Preserved"}, "tags": ["cardiology", "rct", "landmark-trial"]}
{"id": "ext-007", "agent": "agent-stage2-extract", "input": {"pmid": "78901234", "title": "Exercise for depression in adolescents", "abstract": "Objective: Evaluate exercise interventions for adolescent depression. Design: Network meta-analysis of 35 RCTs (n=3500). Interventions: Aerobic, resistance, mixed, yoga vs usual care. Outcome: Depression scores (BDI/CESD). Results: All exercise types superior to control. Aerobic: SMD=-0.62, Resistance: SMD=-0.48, Yoga: SMD=-0.53. SUCRA rankings favor aerobic. No serious adverse events.", "study_type": "network-meta-analysis"}, "expected_output": {"intervention": "exercise (aerobic, resistance, yoga)", "control": "usual care", "outcome_primary": "depression scores (BDI/CESD)", "sample_size": 3500, "effect_size": {"aerobic": "SMD=-0.62", "resistance": "SMD=-0.48", "yoga": "SMD=-0.53"}, "study_design": "network meta-analysis", "n_studies": 35, "population": "adolescents"}, "tags": ["psychiatry", "network-meta-analysis", "pediatrics"]}
{"id": "ext-008", "agent": "agent-stage2-extract", "input": {"pmid": "89012345", "title": "Aspirin for primary prevention", "abstract": "Context: Aspirin's role in primary prevention debated. Study: Pooled individual participant data from 13 trials (164,000 participants). Outcome: Major adverse cardiovascular events (MACE) and major bleeding. Duration: Mean 6.5 years. Results: Aspirin reduced MACE by 11% (RR 0.89, 95% CI 0.84-0.95) but increased major bleeding by 43% (RR 1.43, 95% CI 1.30-1.56). Net benefit unclear.", "study_type": "meta-analysis"}, "expected_output": {"intervention": "aspirin", "control": "no aspirin", "outcome_primary": "major adverse cardiovascular events", "secondary_outcomes": ["major bleeding"], "sample_size": 164000, "effect_size": {"mace_reduction": "11%", "bleeding_increase": "43%"}, "relative_risk": {"mace": 0.89, "bleeding": 1.43}, "confidence_interval": {"mace": "0.84-0.95", "bleeding": "1.30-1.56"}, "study_design": "individual participant data meta-analysis", "n_studies": 13, "mean_follow_up_years": 6.5}, "tags": ["cardiology", "meta-analysis", "primary-prevention"]}
{"id": "ext-009", "agent": "agent-stage2-extract", "input": {"pmid": "90123456", "title": "Bariatric surgery for type 2 diabetes", "abstract": "Aim: Compare bariatric surgery to intensive medical therapy for T2D. Trial: STAMPEDE, 150 obese patients with uncontrolled T2D randomized 1:1:1 to Roux-en-Y gastric bypass, sleeve gastrectomy, or intensive medical therapy. Primary: HbA1c <6% at 5 years. Results: Surgical arms achieved target in 29% (RYGB) and 23% (sleeve) vs 5% (medical), p<0.001. Mean weight loss: 23%, 19%, 5% respectively.", "study_type": "rct"}, "expected_output": {"intervention": "bariatric surgery (Roux-en-Y, sleeve gastrectomy)", "control": "intensive medical therapy", "outcome_primary": "HbA1c <6% at 5 years", "sample_size": 150, "effect_size": {"rygb": "29% achieved target", "sleeve": "23% achieved target", "medical": "5% achieved target"}, "p_value": 0.001, "study_design": "randomized controlled trial", "weight_loss": {"rygb": "23%", "sleeve": "19%", "medical": "5%"}, "trial_name": "STAMPEDE", "follow_up_years": 5}, "tags": ["endocrinology", "rct", "surgery"]}
{"id": "ext-010", "agent": "agent-stage2-extract", "input": {"pmid": "01234567", "title": "Telemedicine for hypertension management", "abstract": "Background: Telemedicine may improve BP control. Methods: Pragmatic cluster-RCT, 40 primary care clinics (8000 hypertensive patients). Intervention: Remote BP monitoring + pharmacist teleconsultations. Control: Usual care. Outcome: Proportion achieving BP <140/90 at 12 months. Results: Intervention 72% vs control 58%, absolute difference 14% (95% CI 10-18%), p<0.0001. Cost: $50/patient incremental.", "study_type": "cluster-rct"}, "expected_output": {"intervention": "remote blood pressure monitoring + pharmacist teleconsultations", "control": "usual care", "outcome_primary": "blood pressure <140/90 at 12 months", "sample_size": 8000, "effect_size": "14% absolute improvement", "intervention_success_rate": 0.72, "control_success_rate": 0.58, "confidence_interval": "10-18%", "p_value": 0.0001, "study_design": "cluster randomized controlled trial", "n_clusters": 40, "cost_per_patient": "$50"}, "tags": ["cardiology", "telemedicine", "cluster-rct"]}
